Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Return on Sales
Return on Investment
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
An analysis of profitability ratios from 2017 to 2022 reveals a period of significant expansion followed by a sharp contraction in the final fiscal year. While top-line efficiency remained relatively stable, bottom-line profitability and capital efficiency experienced substantial volatility, peaking between 2019 and 2020 before declining significantly by March 31, 2022.
- Gross Profit Margin
- The gross profit margin demonstrated remarkable stability over the six-year period, maintaining a high baseline above 80%. A marginal downward trend is observed, moving from 84.14% in 2017 to 81.76% in 2022, indicating a consistent ability to manage direct costs of goods sold relative to revenue.
- Operating and Net Profit Margins
- Operating profit margins showed steady growth from 20.24% in 2017 to a peak of 29.64% in 2020, before dropping sharply to 13.64% in 2022. Similarly, the net profit margin surged from 11.70% in 2017 to a peak of 33.66% in 2019. However, this metric also saw a significant reduction, ending at 13.23% in 2022. The divergence between the stable gross margin and the falling operating and net margins suggests an increase in operating expenses or non-operating costs in the latter years.
- Return on Equity (ROE) and Return on Assets (ROA)
- Both ROE and ROA followed a similar trajectory, peaking in 2019 at 27.65% and 24.57%, respectively. Following this peak, a consistent downward trend occurred, with ROE falling to 9.08% and ROA falling to 8.16% by March 31, 2022. This decline indicates a reduction in the efficiency with which the company generated profits from its asset base and shareholder equity toward the end of the period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Gross Profit Margin
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Gross profit | 843,595) | 685,615) | 689,578) | 639,865) | 495,168) | 374,677) | |
| Revenue | 1,031,753) | 847,522) | 840,883) | 769,432) | 593,749) | 445,304) | |
| Profitability Ratio | |||||||
| Gross profit margin1 | 81.76% | 80.90% | 82.01% | 83.16% | 83.40% | 84.14% | |
| Benchmarks | |||||||
| Gross Profit Margin, Competitors2 | |||||||
| Abbott Laboratories | 51.54% | 52.21% | — | — | — | — | |
| Elevance Health Inc. | 16.79% | 17.09% | — | — | — | — | |
| Intuitive Surgical Inc. | 67.44% | 69.32% | — | — | — | — | |
| Medtronic PLC | 67.98% | 65.19% | — | — | — | — | |
| UnitedHealth Group Inc. | 24.09% | 23.60% | — | — | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Gross profit margin = 100 × Gross profit ÷ Revenue
= 100 × 843,595 ÷ 1,031,753 = 81.76%
2 Click competitor name to see calculations.
Between March 31, 2017, and March 31, 2022, a consistent expansion in top-line revenue and absolute gross profit is observed, although the gross profit margin experienced a gradual contraction over the majority of the period.
- Revenue Growth
- Revenue increased steadily from 445.3 million USD in 2017 to 1.03 billion USD in 2022. The growth trajectory was most aggressive between 2017 and 2019, followed by a period of relative stabilization between 2020 and 2021, and concluding with a significant increase in the final fiscal year.
- Gross Profit Performance
- Absolute gross profit followed a similar upward trend, rising from 374.7 million USD in 2017 to 843.6 million USD in 2022. A slight contraction in gross profit was noted in 2021, mirroring the stagnation in revenue growth during that period.
- Gross Profit Margin Trends
- The gross profit margin exhibited a consistent downward trend for five consecutive years, declining from 84.14% in 2017 to 80.90% in 2021. This suggests a gradual increase in the cost of sales relative to total revenue. However, this trend reversed in 2022, with the margin improving to 81.76%, indicating a stabilization and partial recovery of production efficiency or pricing power.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Operating Profit Margin
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Income from operations | 140,720) | 229,557) | 249,219) | 224,812) | 157,137) | 90,138) | |
| Revenue | 1,031,753) | 847,522) | 840,883) | 769,432) | 593,749) | 445,304) | |
| Profitability Ratio | |||||||
| Operating profit margin1 | 13.64% | 27.09% | 29.64% | 29.22% | 26.47% | 20.24% | |
| Benchmarks | |||||||
| Operating Profit Margin, Competitors2 | |||||||
| Abbott Laboratories | 19.16% | 19.56% | — | — | — | — | |
| Elevance Health Inc. | 4.94% | 5.15% | — | — | — | — | |
| Intuitive Surgical Inc. | 25.35% | 31.89% | — | — | — | — | |
| Medtronic PLC | 18.15% | 14.89% | — | — | — | — | |
| UnitedHealth Group Inc. | 8.83% | 8.40% | — | — | — | — | |
| Operating Profit Margin, Sector | |||||||
| Health Care Equipment & Services | 9.26% | 9.13% | — | — | — | — | |
| Operating Profit Margin, Industry | |||||||
| Health Care | 18.74% | 18.04% | — | — | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Operating profit margin = 100 × Income from operations ÷ Revenue
= 100 × 140,720 ÷ 1,031,753 = 13.64%
2 Click competitor name to see calculations.
The operational performance from 2017 to 2022 is characterized by an initial phase of strong growth and margin expansion, followed by a significant contraction in profitability during the final year, despite continued revenue growth.
- Revenue Trajectory
- A consistent upward trend in revenue is observed, growing from US$ 445,304 thousand in 2017 to US$ 1,031,753 thousand by 2022. The growth was particularly steady between 2017 and 2020, with a more pronounced increase occurring in the 2022 fiscal year as total revenue surpassed the one-billion-dollar threshold.
- Operating Income Trends
- Income from operations exhibited a growth phase from 2017 through 2020, peaking at US$ 249,219 thousand. However, a reversal occurred after 2020, with a slight decline in 2021 to US$ 229,557 thousand, followed by a sharp reduction to US$ 140,720 thousand in 2022.
- Operating Profit Margin Analysis
- The operating profit margin experienced a period of expansion between 2017 and 2020, rising from 20.24% to a peak of 29.64%. This indicates an improvement in operational efficiency and cost management relative to sales during this period. Beginning in 2021, a downward trend emerged, culminating in a substantial compression to 13.64% in 2022. This sharp decline is notable because it occurred simultaneously with the highest recorded revenue, suggesting a significant increase in operating expenses that outpaced revenue gains.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Net Profit Margin
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Net income | 136,505) | 225,525) | 203,009) | 259,016) | 112,170) | 52,116) | |
| Revenue | 1,031,753) | 847,522) | 840,883) | 769,432) | 593,749) | 445,304) | |
| Profitability Ratio | |||||||
| Net profit margin1 | 13.23% | 26.61% | 24.14% | 33.66% | 18.89% | 11.70% | |
| Benchmarks | |||||||
| Net Profit Margin, Competitors2 | |||||||
| Abbott Laboratories | 15.88% | 16.42% | — | — | — | — | |
| Elevance Health Inc. | 3.87% | 4.46% | — | — | — | — | |
| Intuitive Surgical Inc. | 21.25% | 29.85% | — | — | — | — | |
| Medtronic PLC | 15.90% | 11.97% | — | — | — | — | |
| UnitedHealth Group Inc. | 6.25% | 6.06% | — | — | — | — | |
| Net Profit Margin, Sector | |||||||
| Health Care Equipment & Services | 7.05% | 7.14% | — | — | — | — | |
| Net Profit Margin, Industry | |||||||
| Health Care | 14.65% | 15.24% | — | — | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Net profit margin = 100 × Net income ÷ Revenue
= 100 × 136,505 ÷ 1,031,753 = 13.23%
2 Click competitor name to see calculations.
Revenue demonstrates a consistent and sustained growth trajectory from 2017 through 2022, increasing from 445.3 million to 1.03 billion US dollars. However, net income and the corresponding net profit margin exhibit significant volatility, characterized by a sharp ascent followed by a substantial contraction.
- Revenue Trends
- A steady upward trend in top-line growth is observed throughout the analyzed period. Revenue grew incrementally each year, culminating in a milestone exceedance of 1 billion US dollars by March 31, 2022.
- Net Profit Margin Fluctuations
- The net profit margin experienced a rapid expansion between 2017 and 2019, rising from 11.70% to a peak of 33.66%. This suggests a period of high operational efficiency or significant scale effects. Following this peak, the margin entered a period of instability, declining to 24.14% in 2020, recovering slightly to 26.61% in 2021, and then sharply dropping to 13.23% in 2022.
- Net Income Divergence
- A notable divergence between revenue growth and net income is evident in the final fiscal year. While revenue reached its highest point in 2022, net income fell to 136.5 million US dollars, down from 225.5 million in the previous year. This decoupling indicates that increased sales did not translate into higher profitability, resulting in a net profit margin that nearly returned to 2017 levels despite a more than two-fold increase in revenue.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Return on Equity (ROE)
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Net income | 136,505) | 225,525) | 203,009) | 259,016) | 112,170) | 52,116) | |
| Stockholders’ equity | 1,503,326) | 1,329,675) | 1,065,466) | 936,890) | 689,524) | 452,071) | |
| Profitability Ratio | |||||||
| ROE1 | 9.08% | 16.96% | 19.05% | 27.65% | 16.27% | 11.53% | |
| Benchmarks | |||||||
| ROE, Competitors2 | |||||||
| Abbott Laboratories | 18.90% | 19.75% | — | — | — | — | |
| Elevance Health Inc. | 16.59% | 16.93% | — | — | — | — | |
| Intuitive Surgical Inc. | 11.98% | 14.32% | — | — | — | — | |
| Medtronic PLC | 9.59% | 7.01% | — | — | — | — | |
| UnitedHealth Group Inc. | 25.87% | 24.09% | — | — | — | — | |
| ROE, Sector | |||||||
| Health Care Equipment & Services | 18.40% | 17.28% | — | — | — | — | |
| ROE, Industry | |||||||
| Health Care | 24.82% | 25.44% | — | — | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
ROE = 100 × Net income ÷ Stockholders’ equity
= 100 × 136,505 ÷ 1,503,326 = 9.08%
2 Click competitor name to see calculations.
The analysis of profitability metrics from 2017 to 2022 reveals a period of significant expansion followed by a contraction in the efficiency of equity utilization. The Return on Equity (ROE) followed a bell-shaped trajectory, reaching a peak in 2019 before entering a steady decline.
- Net Income Volatility
- Net income showed substantial growth in the initial phase, rising from 52,116 thousand dollars in 2017 to a peak of 259,016 thousand dollars in 2019. Subsequent years were marked by instability, culminating in a significant contraction to 136,505 thousand dollars by March 31, 2022.
- Stockholders' Equity Expansion
- Unlike the volatility observed in earnings, stockholders' equity exhibited consistent and uninterrupted growth throughout the period. The equity base increased from 452,071 thousand dollars in 2017 to 1,503,326 thousand dollars in 2022, representing a steady accumulation of capital.
- Return on Equity (ROE) Dynamics
- The ROE increased from 11.53% in 2017 to a maximum of 27.65% in 2019, a trend driven by net income growth that significantly outpaced the increase in equity. From 2020 onward, a consistent downward trend is observed, with the ratio falling to 9.08% by 2022. This deterioration is attributed to the simultaneous occurrence of declining net income and a continuously expanding equity base, which lowered the return generated per unit of shareholder investment.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Return on Assets (ROA)
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Net income | 136,505) | 225,525) | 203,009) | 259,016) | 112,170) | 52,116) | |
| Total assets | 1,673,393) | 1,494,359) | 1,216,462) | 1,054,346) | 786,375) | 550,414) | |
| Profitability Ratio | |||||||
| ROA1 | 8.16% | 15.09% | 16.69% | 24.57% | 14.26% | 9.47% | |
| Benchmarks | |||||||
| ROA, Competitors2 | |||||||
| Abbott Laboratories | 9.31% | 9.40% | — | — | — | — | |
| Elevance Health Inc. | 5.86% | 6.26% | — | — | — | — | |
| Intuitive Surgical Inc. | 10.19% | 12.58% | — | — | — | — | |
| Medtronic PLC | 5.54% | 3.87% | — | — | — | — | |
| UnitedHealth Group Inc. | 8.19% | 8.15% | — | — | — | — | |
| ROA, Sector | |||||||
| Health Care Equipment & Services | 7.49% | 7.28% | — | — | — | — | |
| ROA, Industry | |||||||
| Health Care | 9.66% | 9.46% | — | — | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
ROA = 100 × Net income ÷ Total assets
= 100 × 136,505 ÷ 1,673,393 = 8.16%
2 Click competitor name to see calculations.
The Return on Assets (ROA) exhibited a bell-shaped trajectory between 2017 and 2022, characterized by an initial period of rapid efficiency gains followed by a sustained decline. While the capacity to generate profit from assets improved significantly during the first three years, the subsequent period indicates a diminishing return on the company's expanding resource base.
- Asset Base Expansion
- A consistent upward trend is observed in total assets, which grew steadily from 550.4 million in 2017 to 1.67 billion by 2022. This indicates a continuous accumulation of resources and capital investment over the six-year period.
- Net Income Dynamics
- Net income grew aggressively from 2017, reaching a peak of 259.0 million in 2019. However, profitability became volatile thereafter, experiencing a contraction in 2020, a slight recovery in 2021, and a sharp decline to 136.5 million by 2022.
- ROA Performance and Efficiency
- The ROA increased from 9.47% in 2017 to a peak of 24.57% in 2019, reflecting a period of high operational leverage and efficiency. Following this peak, a persistent downward trend occurred, with the ratio falling to 16.69% in 2020, 15.09% in 2021, and ultimately 8.16% in 2022. The decline in the latter years is attributed to the divergence between steadily increasing total assets and declining net income, resulting in the lowest asset utilization efficiency of the entire period by the end of the analysis.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?